Exagen Inc Ordinary Shares XGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $8.17
- Day Range
- $7.98–8.55
- 52-Week Range
- $2.59–12.23
- Bid/Ask
- $6.90 / $8.98
- Shares Outstanding
- 24.23M
- Market Cap
- $203.98M
- Volume/Avg
- 251,153 / 327,918
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.80
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 220
- Website
- https://www.exagen.com
Valuation
|
Metric
|
XGN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 16.68 |
Price/Sales | 2.80 |
Price/Cash Flow | — |
Price/Earnings
XGN
Financial Strength
|
Metric
|
XGN
|
|---|---|
Quick Ratio | 2.75 |
Current Ratio | 3.18 |
Interest Coverage | −2.70 |
Quick Ratio
XGN
Profitability
|
Metric
|
XGN
|
|---|---|
Return on Assets (Normalized) | −28.44% |
Return on Equity (Normalized) | −96.81% |
Return on Invested Capital (Normalized) | −28.67% |
Return on Assets
XGN
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|?Brqt>J | LOCK|NS> | $243B | |||
| Danaher Corp
DHR
| LOCK|<<?Npv> | LOCK|GB | $155B | |||
| Agilent Technologies Inc
A
| LOCK|l##lXSZb | LOCK|c@ | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|@&hcvc | LOCK|kh#L | $43B | |||
| Waters Corp
WAT
| LOCK|lfBt@@@ | LOCK|DX | $43B | |||
| Illumina Inc
ILMN
| LOCK|<!zR&< | LOCK|w<hm | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|j!<@???$ | LOCK|x@P | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|&@MHX?Np | LOCK|!m?Xq | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|tzsQ$Cs | LOCK|@>P@ | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|nP$<wpN | LOCK|>mdT> | $25B |
United States